Akebia Therapeutics, Inc. To Present At The 27th Annual ROTH Conference

ebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that Jason A. Amello, Senior Vice President and Chief Financial Officer, will present at the 27th Annual ROTH Conference on Wednesday, March 11, 2015, at 9:00 a.m. Pacific Time. The conference is being held at the Ritz Carlton in Dana Point, California.

Help employers find you! Check out all the jobs and post your resume.

Back to news